effect | 4 |
potential | 4 |
metabolite | 2 |
cross the placenta | 0.47 |
prevent recurrence of a… | 0.41 |
inhibit cyp3a4 activity | 0.32 |
inhibit co | 0.32 |
take with procainamide | 0.31 |
prolong phase | 0.25 |
reduce scd | 0.25 |
caused sinus arrest | 0.16 |
cause thyroid problems | 0.16 |
keep the heart | 0.16 |
hyperthyroidism | 0.41 |
side effects | 0.35 |
either hypothyroidism | 0.35 |
bradycardia | 0.32 |
heart block | 0.16 |
pulmonary fibrosis | 0.16 |
effective | 0.59 |
safe | 0.46 |
suitable | 0.41 |
toxic | 0.38 |
unavailable | 0.36 |
dialyzable | 0.35 |
superior | 0.25 |
helpful | 0.16 |
higher rate of survival | 0.31 |
increased exposure | 0.16 |
the drug | 0.58 |
benzofuran derivative | 0.25 |
administered | 0.56 |
discontinued | 0.52 |
started | 0.50 |
avoided in pregnant pat… | 0.32 |
continued | 0.31 |
compared to placebo | 0.28 |
compared with lidocaine | 0.25 |
stopped | 0.23 |
excreted | 0.23 |